Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • joshualpollack
    Junior Member
    • Jul 2017
    • 1

    scSeq Analysis - Seurat and OOBE usage

    Hi all,

    I have a specific stats question, that is a bit deep in the weeds (for me anyway, and also reveals some of my shortcomings, in terms of understanding the background statistical techniques regarding random forests…).

    I'm attempting to use the Out of Bag Error classification that is suggested in Seurat's pbmc33k code object on my own dataset. The general idea is to over cluster your single cell data and then merge the clusters that are very similar (as assessed by the out of bag error stat). I do have a couple of questions however:

    1) How does one assess how many nodes need to be merged? In the pbmc example, the authors choose 8, based on "High OOBE" scores. From reading a bit, however, it appears those scores are fairly dataset specific. Do you have
    any suggestions as to any methodologies for this choice? (I paste the OOBE results from my dataset below).

    2) Also, it seems possible that one could have overclustering within 2 (or more) transcriptionally distinct
    sets of cells (let's say within dendritic cells and within macrophages). Presumably, this means you'd have to merge twice, somehow? Once within DCs and once within Macs? Is this possible? My understanding is the list below is ranked by the OOBE and you could different nodes with high OOBE that arise from very different cell types that you’d not want to merge together?

    Thanks so much, in advance.

    All the best,

    Josh










    node oobe
    59 0.2836879433
    57 0.2592592593
    60 0.2268518519
    46 0.1829971182
    49 0.1818181818
    54 0.1736694678
    56 0.1533546326
    47 0.1404682274
    51 0.1338582677
    43 0.1255374033
    36 0.1246226822
    58 0.1213592233
    48 0.1197771588
    61 0.1168831169
    33 0.1158497772
    45 0.1148036254
    39 0.1109399076
    53 0.1069958848
    50 0.0796812749
    44 0.0705882353
    37 0.0672131148
    40 0.0599078341
    34 0.0588235294
    38 0.0510752688
    55 0.0474777448
    41 0.0471063257
    42 0.0340531561
    35 0.0196319018
    52 0.0122699387
    32 0.0006361323

Latest Articles

Collapse

  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM
  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    07-08-2026, 05:17 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Today, 12:17 PM
0 responses
9 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, Yesterday, 11:41 AM
0 responses
10 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-20-2026, 11:10 AM
0 responses
23 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-13-2026, 10:26 AM
0 responses
37 views
0 reactions
Last Post SEQadmin2  
Working...